marketcaparena
Search

    VTRS

    Viatris Inc

    Company overview

    Market capitalization
    $20.98B
    Employees
    30,000
    Latest publication
    2026-09-29
    About Viatris Inc

    Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CNS and anesthesia, dermatology, diabetes and metabolism, eye care, gastroenterology, immunology, oncology, and respiratory and allergy, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. In addition, the company offers medicines in the form of oral solid doses, injectables, and complex dosage forms to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies under the Lyrica, Lipitor, Celebrex, Viagra, Creon, Influvac, Wixela Inhub, EpiPen Auto-Injector, Fraxiparine, Yupelri, Norvasc, Amitiza, Effexor, Lipacreon, Zoloft, Xalabrands, Dymista, Xanax, and Breyna brands. The company has collaboration agreements with Mapi Pharma Ltd. to develop and commercialize long-acting glatiramer acetate depot products and additional products; Revance Therapeutics, Inc. to develop, manufacture, and commercialize a biosimilar to the branded biologic product, BOTOX; and Theravance Biopharma, Inc. to develop and commercialize revefenacin. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ3 20242024-09-30 · USDQ1 20242024-03-31 · USDQ3 20232023-09-30 · USDQ2 20232023-06-30 · USDQ1 20232023-03-31 · USD
    Total Revenue3,756,800,000USD3,759,900,000USD3,582,100,000USD3,751,200,000USD3,663,400,000USD3,941,900,000USD3,918,600,000USD3,729,100,000USD
    Cost Of Revenue2,300,300,000USD2,375,000,000USD2,249,200,000USD2,292,000,000USD2,159,400,000USD2,250,600,000USD2,310,000,000USD2,186,900,000USD
    Gross Profit1,456,500,000USD1,384,900,000USD1,332,900,000USD1,459,200,000USD1,504,000,000USD1,691,300,000USD1,608,600,000USD1,542,200,000USD
    Research Development248,300,000USD250,400,000USD218,800,000USD198,400,000USD199,700,000USD211,200,000USD208,300,000USD182,900,000USD
    Selling General Administrative1,134,500,000USD886,600,000USD928,700,000USD1,003,400,000USD1,017,500,000USD1,053,500,000USD1,031,900,000USD958,900,000USD
    Total Operating Expenses1,450,200,000USD1,133,300,000USD1,099,900,000USD1,233,300,000USD1,300,100,000USD1,239,600,000USD1,239,400,000USD1,142,400,000USD
    Operating Income6,300,000USD251,600,000USD233,000,000USD225,900,000USD203,900,000USD451,700,000USD369,200,000USD399,800,000USD
    Total Other Income Expense Net-70,300,000USD-259,500,000USD-450,100,000USD-135,400,000USD700,000USD-49,500,000USD-36,200,000USD-77,100,000USD
    Interest Expense120,700,000USD119,600,000USD116,600,000USD145,600,000USD138,400,000USD141,500,000USD143,700,000USD147,000,000USD
    Income Before Tax-64,000,000USD-7,900,000USD-217,100,000USD90,500,000USD204,600,000USD402,200,000USD333,000,000USD322,700,000USD
    Income Tax Expense54,800,000USD120,300,000USD-212,500,000USD-4,300,000USD90,700,000USD70,600,000USD69,000,000USD98,000,000USD
    Net Income-118,800,000USD-128,199,999USD-4,600,000USD94,800,000USD113,900,000USD331,600,000USD264,000,000USD224,700,000USD
    Net Income Applicable To Common Shares-118,800,000USD————331,600,000USD264,000,000USD224,700,000USD
    Net Interest Income—-119,600,000USD-116,600,000USD-145,600,000USD-138,400,000USD-141,500,000USD-143,700,000USD-147,000,000USD
    Tax Provision—120,300,000USD-212,500,000USD-4,300,000USD90,700,000USD70,600,000USD69,000,000USD98,000,000USD
    Net Income From Continuing Ops—-128,200,000USD-4,600,000USD94,800,000USD113,900,000USD331,600,000USD264,000,000USD224,700,000USD
    Ebit—111,700,000USD-100,500,000USD236,100,000USD343,000,000USD543,700,000USD476,700,000USD469,700,000USD
    Ebitda—800,200,000USD577,800,000USD905,800,000USD1,034,000,000USD1,223,100,000USD1,163,400,000USD1,199,700,000USD
    Depreciation And Amortization—688,500,000USD678,300,000USD669,700,000USD691,000,000USD679,400,000USD686,700,000USD730,000,000USD
    Reconciled Depreciation—688,500,000USD678,300,000USD669,700,000USD691,000,000USD679,400,000USD686,700,000USD730,000,000USD
    Unclassified Operating Expenses——-47,600,000USD31,500,000USD82,900,000USD-25,100,000USD——
    Non Operating Income Net Other——————107,500,000USD69,900,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Total Revenue14,739,300,000USD15,426,900,000USD16,262,700,000USD17,886,300,000USD11,500,500,000USD11,433,900,000USD11,907,700,000USD11,076,900,000USD
    Cost Of Revenue9,115,700,000USD8,988,300,000USD9,765,700,000USD12,310,800,000USD7,602,900,000USD7,432,300,000USD7,124,600,000USD6,379,900,000USD
    Gross Profit5,623,600,000USD6,438,600,000USD6,497,000,000USD5,575,500,000USD3,897,600,000USD4,001,600,000USD4,783,100,000USD4,697,000,000USD
    Research Development808,700,000USD805,200,000USD662,200,000USD681,000,000USD639,900,000USD704,500,000USD783,300,000USD826,800,000USD
    Selling General Administrative4,425,600,000USD4,309,700,000USD4,179,100,000USD4,529,200,000USD2,563,600,000USD2,441,000,000USD2,575,800,000USD2,496,100,000USD
    Unclassified Operating Expenses379,200,000USD557,500,000USD—399,300,000USD—-49,500,000USD—674,900,000USD
    Total Operating Expenses5,613,500,000USD5,672,400,000USD4,882,100,000USD5,609,500,000USD3,182,100,000USD3,096,000,000USD3,345,900,000USD3,997,800,000USD
    Operating Income10,100,000USD766,200,000USD1,614,900,000USD-34,000,000USD715,500,000USD905,600,000USD1,437,200,000USD699,200,000USD
    Interest Expense550,000,000USD573,100,000USD592,400,000USD636,200,000USD517,300,000USD542,300,000USD534,600,000USD454,800,000USD
    Net Interest Income-550,000,000USD-579,300,000USD-592,400,000USD-636,200,000USD-517,300,000USD-542,300,000USD-528,400,000USD-442,500,000USD
    Income Before Tax-623,200,000USD202,900,000USD2,813,200,000USD-664,400,000USD154,400,000USD298,400,000USD903,000,000USD121,700,000USD
    Income Tax Expense11,000,000USD148,200,000USD734,600,000USD604,700,000USD137,600,000USD-54,100,000USD207,000,000USD-358,300,000USD
    Tax Provision11,000,000USD695,300,000USD734,600,000USD604,700,000USD137,600,000USD-54,100,000USD207,000,000USD-358,300,000USD
    Net Income-634,200,000USD54,700,000USD2,078,600,000USD-1,269,100,000USD16,800,000USD352,500,000USD696,000,000USD480,000,000USD
    Net Income From Continuing Ops-634,200,000USD1,831,500,000USD2,078,600,000USD-1,269,100,000USD16,800,000USD352,500,000USD696,000,000USD480,000,000USD
    Ebit-73,200,000USD776,000,000USD3,405,600,000USD-28,200,000USD671,700,000USD840,700,000USD1,437,600,000USD576,500,000USD
    Ebitda2,820,000,000USD3,516,500,000USD6,433,200,000USD4,478,300,000USD2,691,000,000USD2,950,600,000USD3,243,400,000USD2,099,500,000USD
    Depreciation And Amortization2,893,200,000USD2,740,500,000USD3,027,600,000USD4,506,500,000USD2,019,300,000USD2,109,900,000USD1,805,800,000USD1,523,000,000USD
    Reconciled Depreciation2,893,200,000USD2,965,900,000USD3,027,600,000USD4,506,500,000USD2,019,300,000USD2,109,900,000USD1,805,800,000USD—
    Total Other Income Expense Net-633,300,000USD-563,300,000USD1,198,300,000USD-630,400,000USD-561,100,000USD-607,200,000USD-534,200,000USD-577,500,000USD
    Net Income Applicable To Common Shares——2,078,600,000USD-1,269,100,000USD16,800,000USD352,500,000USD696,000,000USD480,000,000USD
    Interest Income——————6,200,000USD12,300,000USD
    Minority Interest——————0USD1,400,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets35,044,600,000USD36,834,600,000USD37,193,100,000USD37,920,400,000USD38,411,500,000USD38,474,900,000USD41,500,900,000USD44,754,100,000USD
    Cash And Equivalents886,500,000USD———————
    Total Current Assets10,055,700,000USD10,916,800,000USD9,220,900,000USD9,951,400,000USD9,774,600,000USD9,622,400,000USD9,520,700,000USD11,307,700,000USD
    Other Current Assets139,600,000USD2,109,300,000USD420,200,000USD1,095,700,000USD1,104,400,000USD1,135,300,000USD1,054,700,000USD1,230,500,000USD
    Other Non Current Assets1,060,200,000USD———————
    Total Liabilities20,784,200,000USD———————
    Total Current Liabilities6,345,800,000USD6,810,300,000USD7,094,300,000USD7,364,100,000USD7,133,400,000USD5,720,100,000USD5,779,400,000USD7,512,400,000USD
    Other Current Liabilities2,880,400,000USD———————
    Other Non Current Liabilities2,023,200,000USD———————
    Total Equity Including Noncontrolling Interest14,260,400,000USD———————
    Short Long Term Debt1,738,900,000USD1,927,600,000USD1,929,900,000USD1,944,300,000USD1,673,100,000USD700,000USD600,000USD1,446,400,000USD
    Long Term Debt11,612,400,000USD12,413,500,000USD12,480,600,000USD12,487,600,000USD12,791,600,000USD14,177,500,000USD14,038,900,000USD14,303,400,000USD
    Net Receivables3,126,200,000USD3,076,300,000USD3,347,100,000USD3,587,200,000USD3,597,300,000USD3,388,500,000USD3,522,000,000USD3,944,900,000USD
    Inventory3,933,200,000USD3,927,000,000USD3,999,200,000USD4,111,400,000USD4,264,300,000USD4,096,400,000USD3,854,100,000USD4,084,600,000USD
    Property Plant Equipment Net2,698,800,000USD2,527,900,000USD2,885,300,000USD2,892,100,000USD2,918,900,000USD2,901,500,000USD2,919,200,000USD2,944,500,000USD
    Goodwill6,654,400,000USD———————
    Intangible Assets13,676,900,000USD14,482,300,000USD15,102,100,000USD15,722,900,000USD16,323,800,000USD16,662,300,000USD17,070,900,000USD17,978,900,000USD
    Accounts Payable1,726,500,000USD1,749,400,000USD1,293,700,000USD1,326,400,000USD1,320,000,000USD1,518,200,000USD1,355,300,000USD1,242,200,000USD
    Short Term Debt1,736,200,000USD1,931,100,000USD2,042,700,000USD2,056,200,000USD1,784,700,000USD103,900,000USD87,700,000USD1,530,600,000USD
    Common Stock12,600,000USD12,600,000USD12,500,000USD12,500,000USD12,500,000USD12,400,000USD12,300,000USD12,300,000USD
    Retained Earnings-330,700,000USD-211,900,000USD-388,300,000USD-48,200,000USD80,000,000USD227,900,000USD3,418,800,000USD4,082,000,000USD
    Accumulated Other Comprehensive Income-2,824,800,000USD-2,799,800,000USD-2,707,000,000USD-2,713,200,000USD-2,664,400,000USD-2,870,900,000USD-3,212,900,000USD-2,686,300,000USD
    Total Stockholder Equity14,260,400,000USD14,657,700,000USD14,711,300,000USD15,217,600,000USD15,570,500,000USD15,650,400,000USD18,635,500,000USD19,792,400,000USD
    Total Liab—22,176,900,000USD22,481,800,000USD22,702,800,000USD22,841,000,000USD22,824,500,000USD22,865,400,000USD24,961,700,000USD
    Other Current Liab—3,129,800,000USD3,757,900,000USD3,981,500,000USD4,028,700,000USD4,004,600,000USD4,143,700,000USD4,455,500,000USD
    Capital Stock—12,600,000USD12,500,000USD12,500,000USD12,500,000USD12,400,000USD12,300,000USD12,300,000USD
    Good Will—6,692,400,000USD6,754,700,000USD6,730,800,000USD6,748,300,000USD6,462,100,000USD9,133,300,000USD9,561,700,000USD
    Cash—1,804,200,000USD1,348,000,000USD975,300,000USD566,400,000USD755,000,000USD734,800,000USD1,878,700,000USD
    Cash And Short Term Investments—1,804,200,000USD1,454,400,000USD1,157,100,000USD808,600,000USD1,002,200,000USD1,089,900,000USD2,047,700,000USD
    Net Debt—12,540,400,000USD13,353,400,000USD13,739,900,000USD14,191,900,000USD13,703,500,000USD13,571,100,000USD14,143,400,000USD
    Short Long Term Debt Total—14,344,600,000USD14,701,400,000USD14,715,200,000USD14,758,300,000USD14,458,500,000USD14,305,900,000USD16,022,100,000USD
    Long Term Investments—0USD815,000,000USD850,000,000USD950,000,000USD1,234,000,000USD1,349,800,000USD1,477,100,000USD
    Short Term Investments—596,000,000USD106,400,000USD181,800,000USD242,200,000USD247,200,000USD355,100,000USD169,000,000USD
    Property Plant Equipment Gross—5,360,700,000USD5,406,000,000USD5,372,400,000USD5,343,500,000USD5,205,600,000USD5,122,400,000USD5,152,400,000USD
    Common Stock Shares Outstanding—1,175,300,000shares1,152,600,000shares1,164,600,000shares1,173,000,000shares1,192,400,000shares1,193,300,000shares1,200,400,000shares
    Non Current Assets Total—25,917,800,000USD27,972,200,000USD27,969,000,000USD28,636,900,000USD28,852,500,000USD31,980,200,000USD33,446,400,000USD
    Non Current Liabilities Total—15,366,600,000USD15,387,500,000USD15,338,700,000USD15,707,600,000USD17,104,400,000USD17,086,000,000USD17,449,300,000USD
    Non Current Liabilities Other—987,100,000USD962,000,000USD723,400,000USD715,100,000USD712,300,000USD821,600,000USD734,100,000USD
    Non Currrent Assets Other—1,106,000,000USD1,353,900,000USD774,200,000USD771,600,000USD775,000,000USD754,000,000USD721,100,000USD
    Net Working Capital—4,106,500,000USD2,694,900,000USD2,587,300,000USD2,641,200,000USD3,902,300,000USD3,741,300,000USD3,795,300,000USD
    Unclassified Current Assets—-596,000,000USD——————
    Unclassified Non Current Assets—1,109,200,000USD1,061,200,000USD999,000,000USD924,300,000USD817,600,000USD753,000,000USD763,100,000USD
    Unclassified Current Liabilities—-1,927,600,000USD-1,929,900,000USD-1,944,300,000USD-1,673,100,000USD92,700,000USD192,100,000USD-1,162,300,000USD
    Unclassified Non Current Liabilities—1,966,000,000USD1,944,900,000USD2,127,700,000USD2,200,900,000USD2,214,600,000USD2,225,500,000USD2,411,800,000USD
    Unclassified Equity—17,644,200,000USD17,781,600,000USD17,954,000,000USD18,129,900,000USD18,268,600,000USD18,405,000,000USD18,372,100,000USD
    Current Deferred Revenue——————-7,700,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets37,193,100,000USD41,500,900,000USD47,685,500,000USD50,022,200,000USD54,842,800,000USD61,553,000,000USD31,255,500,000USD32,734,900,000USD
    Intangible Assets15,102,100,000USD17,070,900,000USD19,181,100,000USD22,607,100,000USD26,134,200,000USD29,683,200,000USD11,649,900,000USD13,664,600,000USD
    Other Current Assets420,200,000USD1,054,700,000USD4,281,400,000USD1,500,500,000USD1,723,800,000USD1,503,900,000USD442,900,000USD921,800,000USD
    Total Liab22,481,800,000USD22,865,400,000USD27,218,100,000USD28,949,900,000USD34,350,100,000USD38,598,900,000USD19,371,700,000USD20,567,800,000USD
    Total Stockholder Equity14,711,300,000USD18,635,500,000USD20,467,400,000USD21,072,300,000USD20,492,700,000USD22,954,100,000USD11,883,800,000USD12,167,100,000USD
    Other Current Liab3,757,900,000USD4,143,700,000USD4,151,500,000USD3,977,500,000USD5,151,400,000USD5,426,300,000USD2,759,900,000USD2,564,500,000USD
    Common Stock12,500,000USD12,300,000USD12,200,000USD12,100,000USD12,100,000USD12,100,000USD6,100,000USD6,000,000USD
    Capital Stock12,500,000USD12,300,000USD12,200,000USD12,100,000USD12,100,000USD12,100,000USD6,100,000USD6,000,000USD
    Retained Earnings-388,300,000USD3,418,800,000USD4,639,700,000USD5,175,600,000USD3,688,800,000USD5,361,200,000USD6,031,100,000USD6,010,700,000USD
    Good Will6,754,700,000USD9,133,300,000USD9,867,100,000USD10,425,800,000USD12,113,700,000USD12,347,000,000USD9,590,600,000USD9,747,800,000USD
    Cash1,348,000,000USD734,800,000USD991,900,000USD1,259,900,000USD701,200,000USD844,400,000USD475,600,000USD388,100,000USD
    Cash And Short Term Investments1,454,400,000USD1,089,900,000USD1,184,400,000USD1,472,500,000USD935,000,000USD1,047,900,000USD584,700,000USD449,200,000USD
    Total Current Assets9,220,900,000USD9,520,700,000USD12,976,100,000USD10,635,400,000USD10,902,900,000USD12,867,500,000USD6,757,300,000USD6,367,700,000USD
    Total Current Liabilities7,094,300,000USD5,779,400,000USD7,777,400,000USD6,746,200,000USD9,884,400,000USD10,562,900,000USD5,569,100,000USD4,587,800,000USD
    Net Debt13,353,400,000USD13,571,100,000USD17,379,300,000USD18,267,800,000USD22,656,800,000USD25,316,600,000USD12,448,700,000USD13,430,200,000USD
    Short Term Debt2,042,700,000USD87,700,000USD2,017,700,000USD1,331,100,000USD3,440,000,000USD3,502,300,000USD1,534,300,000USD657,100,000USD
    Short Long Term Debt1,929,900,000USD600,000USD1,934,700,000USD1,250,500,000USD1,877,500,000USD3,357,200,000USD567,500,000USD657,100,000USD
    Short Long Term Debt Total14,701,400,000USD14,305,900,000USD18,371,200,000USD19,527,700,000USD23,358,000,000USD26,161,000,000USD12,924,300,000USD13,818,300,000USD
    Long Term Debt12,480,600,000USD14,038,900,000USD16,188,100,000USD18,015,200,000USD19,717,100,000USD22,429,200,000USD11,214,300,000USD13,161,200,000USD
    Long Term Investments815,000,000USD1,349,800,000USD1,142,000,000USD1,091,400,000USD81,400,000USD47,900,000USD92,200,000USD138,700,000USD
    Short Term Investments106,400,000USD355,100,000USD192,500,000USD212,600,000USD233,800,000USD203,500,000USD109,100,000USD57,500,000USD
    Net Receivables3,347,100,000USD3,522,000,000USD4,040,600,000USD4,142,900,000USD4,266,400,000USD4,843,800,000USD3,058,800,000USD2,416,500,000USD
    Inventory3,999,200,000USD3,854,100,000USD3,469,700,000USD3,519,500,000USD3,977,700,000USD5,471,900,000USD2,670,900,000USD2,580,200,000USD
    Accounts Payable1,293,700,000USD1,355,300,000USD1,381,400,000USD1,158,000,000USD1,056,100,000USD1,345,700,000USD1,061,900,000USD1,244,700,000USD
    Property Plant Equipment Net2,885,300,000USD2,919,200,000USD3,005,200,000USD3,283,800,000USD3,479,400,000USD3,783,500,000USD2,404,200,000USD2,170,200,000USD
    Property Plant Equipment Gross5,406,000,000USD5,122,400,000USD5,015,900,000USD5,343,100,000USD5,879,900,000USD3,783,500,000USD2,404,200,000USD2,170,200,000USD
    Accumulated Other Comprehensive Income-2,707,000,000USD-3,212,900,000USD-2,747,400,000USD-2,761,200,000USD-1,744,300,000USD-858,000,000USD-1,797,200,000USD-1,441,300,000USD
    Common Stock Shares Outstanding1,170,700,000shares1,193,300,000shares1,206,900,000shares1,217,400,000shares1,208,800,000shares601,200,000shares516,500,000shares516,500,000shares
    Non Current Assets Total27,972,200,000USD31,980,200,000USD34,709,400,000USD39,386,800,000USD43,939,900,000USD48,685,500,000USD24,498,200,000USD26,367,200,000USD
    Non Current Liabilities Total15,387,500,000USD17,086,000,000USD19,440,700,000USD22,203,700,000USD24,465,700,000USD28,036,000,000USD13,802,600,000USD15,980,000,000USD
    Non Current Liabilities Other962,000,000USD821,600,000USD388,700,000USD555,500,000USD4,748,600,000USD628,900,000USD266,600,000USD537,000,000USD
    Non Currrent Assets Other1,353,900,000USD754,000,000USD821,100,000USD1,052,800,000USD798,500,000USD676,000,000USD58,200,000USD73,700,000USD
    Net Working Capital2,694,900,000USD3,741,300,000USD5,198,700,000USD3,889,200,000USD1,018,500,000USD2,304,600,000USD1,188,200,000USD1,779,900,000USD
    Unclassified Non Current Assets1,061,200,000USD753,000,000USD692,900,000USD-2,050,200,000USD-4,359,300,000USD-1,049,100,000USD——
    Unclassified Current Liabilities-1,929,900,000USD192,100,000USD-4,786,300,000USD-3,064,500,000USD-5,705,200,000USD-5,655,300,000USD-1,892,100,000USD-1,752,500,000USD
    Unclassified Non Current Liabilities1,944,900,000USD2,225,500,000USD2,863,900,000USD-374,100,000USD-4,547,700,000USD-399,400,000USD—-537,000,000USD
    Unclassified Equity17,781,600,000USD18,405,000,000USD18,550,700,000USD18,633,700,000USD18,524,000,000USD18,426,700,000USD7,637,700,000USD7,585,700,000USD
    Current Deferred Revenue—-279,800,000USD3,078,400,000USD2,093,600,000USD4,064,600,000USD2,586,700,000USD1,537,600,000USD1,216,900,000USD
    Other Liab———4,007,100,000USD4,547,700,000USD5,377,300,000USD2,412,600,000USD2,818,800,000USD
    Other Assets———2,976,100,000USD5,692,000,000USD3,197,000,000USD761,300,000USD645,900,000USD
    Net Tangible Assets———-11,960,600,000USD-17,755,200,000USD-19,076,100,000USD-9,356,700,000USD-11,245,300,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation1,348,400,000USD
    Stock Based Compensation86,900,000USD
    Deferred Income Tax-194,200,000USD
    Other Non Cash Items-377,300,000USD
    Change To Account Receivables-252,800,000USD
    Change To Inventory-222,500,000USD
    Change In Working Capital-897,800,000USD
    Operating Cash Flow770,100,000USD
    Capital Expenditures-92,700,000USD
    Net Investments0USD
    Other Investing Activities92,800,000USD
    Unclassified Investing Cash Flow225,700,000USD
    Investing Cash Flow225,800,000USD
    Net Debt Issuance-922,200,000USD
    Net Common Stock Issuance-206,800,000USD
    Other Financing Activities-304,200,000USD
    Unclassified Financing Cash Flow-13,200,000USD
    Financing Cash Flow-1,446,400,000USD
    Effect Of Forex Changes On Cash-7,500,000USD
    Change In Cash-458,000,000USD
    End Cash Flow890,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income176,400,000USD-340,100,000USD-128,200,000USD-4,600,000USD-3,042,000,000USD-516,500,000USD94,800,000USD-326,400,000USD
    Depreciation676,100,000USD766,800,000USD688,500,000USD678,300,000USD664,700,000USD746,200,000USD669,700,000USD786,300,000USD
    Stock Based Compensation48,200,000USD49,400,000USD36,000,000USD37,100,000USD55,200,000USD32,300,000USD32,400,000USD34,700,000USD
    Other Non Cash Items260,200,000USD2,014,000,000USD159,800,000USD538,700,000USD3,123,100,000USD314,900,000USD203,300,000USD253,500,000USD
    Change To Account Receivables-126,300,000USD271,900,000USD-95,700,000USD-9,600,000USD168,000,000USD300,500,000USD-33,000,000USD22,800,000USD
    Change To Inventory-123,000,000USD15,800,000USD110,500,000USD-39,000,000USD-193,700,000USD-35,600,000USD-129,000,000USD-188,400,000USD
    Change In Working Capital-702,900,000USD-1,426,100,000USD126,000,000USD-982,300,000USD-221,900,000USD154,700,000USD138,700,000USD-214,600,000USD
    Total Cash From Operating Activities388,300,000USD815,800,000USD744,900,000USD219,700,000USD535,500,000USD482,700,000USD826,500,000USD379,100,000USD
    Capital Expenditures-39,900,000USD-265,300,000USD-99,700,000USD-54,100,000USD-76,400,000USD-153,400,000USD-85,400,000USD-58,800,000USD
    Free Cash Flow348,400,000USD550,500,000USD645,200,000USD165,600,000USD459,100,000USD329,300,000USD741,100,000USD320,300,000USD
    Investments400,000,000USD0USD-98,900,000USD-52,500,000USD-65,100,000USD-168,700,000USD1,747,900,000USD375,800,000USD
    Total Cashflows From Investing Activities277,400,000USD-211,200,000USD-98,900,000USD-52,500,000USD-65,100,000USD-168,700,000USD1,747,900,000USD375,800,000USD
    Net Borrowings0USD-1,600,000USD300,000USD0USD1,400,000USD-1,375,800,000USD-1,536,200,000USD—
    Total Cash From Financing Activities-203,800,000USD-236,400,000USD-228,100,000USD-362,400,000USD-467,000,000USD-1,420,200,000USD-1,636,700,000USD-847,900,000USD
    Dividends Paid-139,600,000USD-138,200,000USD-139,900,000USD-139,800,000USD-143,300,000USD-143,300,000USD-143,200,000USD-145,500,000USD
    Sale Purchase Of Stock0USD-85,100,000USD-65,000,000USD-175,000,000USD-175,400,000USD0USD3,400,000USD-3,400,000USD
    Issuance Of Capital Stock500,000USD600,000USD700,000USD700,000USD600,000USD600,000USD600,000USD700,000USD
    Change In Cash456,200,000USD344,500,000USD435,700,000USD-188,500,000USD20,200,000USD-1,144,000,000USD961,600,000USD-97,400,000USD
    Begin Period Cash Flow1,348,000,000USD1,003,500,000USD567,800,000USD756,300,000USD736,100,000USD1,880,100,000USD918,500,000USD1,015,900,000USD
    End Period Cash Flow1,804,200,000USD1,348,000,000USD1,003,500,000USD567,800,000USD756,300,000USD736,100,000USD1,880,100,000USD918,500,000USD
    Other Cashflows From Investing Activities-2,300,000USD54,100,000USD800,000USD1,600,000USD11,300,000USD-12,700,000USD1,833,300,000USD-3,200,000USD
    Other Cashflows From Financing Activities-64,700,000USD-12,100,000USD-24,200,000USD-48,300,000USD-150,300,000USD98,300,000USD42,100,000USD98,600,000USD
    Unclassified Operating Cash Flow-69,700,000USD-248,200,000USD-137,200,000USD-47,500,000USD-43,600,000USD-248,900,000USD-312,400,000USD-154,400,000USD
    Unclassified Investing Cash Flow-80,400,000USD—98,900,000USD52,500,000USD65,100,000USD166,100,000USD-1,747,900,000USD62,000,000USD
    Unclassified Financing Cash Flow———————-797,600,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-3,514,900,000USD-634,200,000USD54,700,000USD2,078,600,000USD-1,269,100,000USD-669,900,000USD16,800,000USD352,500,000USD
    Depreciation2,798,300,000USD2,708,500,000USD2,740,500,000USD3,027,600,000USD4,506,500,000USD2,216,100,000USD2,019,300,000USD1,888,600,000USD
    Stock Based Compensation177,700,000USD146,100,000USD180,700,000USD116,400,000USD111,200,000USD79,200,000USD56,800,000USD-70,600,000USD
    Other Non Cash Items5,835,600,000USD1,168,700,000USD922,100,000USD-1,321,500,000USD797,400,000USD515,900,000USD411,200,000USD556,600,000USD
    Change To Account Receivables334,600,000USD300,100,000USD78,600,000USD-240,300,000USD59,300,000USD78,700,000USD-20,000,000USD340,100,000USD
    Change To Inventory-106,400,000USD-723,400,000USD-613,300,000USD-259,500,000USD-427,600,000USD-741,900,000USD-512,900,000USD-547,600,000USD
    Change In Working Capital-2,504,300,000USD-318,600,000USD-711,300,000USD-922,600,000USD-1,804,800,000USD-696,300,000USD-507,800,000USD-385,400,000USD
    Total Cash From Operating Activities2,315,900,000USD2,302,900,000USD2,799,600,000USD2,952,600,000USD3,016,900,000USD1,231,800,000USD1,803,700,000USD2,341,700,000USD
    Capital Expenditures-378,800,000USD-326,000,000USD-474,500,000USD-443,000,000USD-509,400,000USD-681,200,000USD-406,000,000USD-252,100,000USD
    Free Cash Flow1,937,100,000USD1,976,900,000USD2,325,100,000USD2,509,600,000USD2,507,500,000USD550,600,000USD1,397,700,000USD2,089,600,000USD
    Investments0USD1,800,700,000USD904,600,000USD1,520,500,000USD-400,000USD-301,100,000USD-525,400,000USD-1,210,400,000USD
    Total Cashflows From Investing Activities-427,700,000USD1,800,700,000USD-764,100,000USD1,520,500,000USD-117,800,000USD-301,100,000USD-525,400,000USD-1,210,400,000USD
    Net Borrowings100,000USD-3,713,700,000USD-1,249,600,000USD-3,280,100,000USD-2,099,100,000USD-401,300,000USD-1,102,900,000USD-631,700,000USD
    Total Cash From Financing Activities-1,293,900,000USD-4,330,400,000USD-2,301,900,000USD-3,877,900,000USD-3,012,000,000USD-605,700,000USD-1,169,000,000USD-1,090,900,000USD
    Dividends Paid-561,200,000USD-574,800,000USD-575,600,000USD-581,600,000USD-399,000,000USD-7,900,000USD-300,000USD-399,000,000USD
    Sale Purchase Of Stock-500,500,000USD-250,000,000USD-250,000,000USD-17,300,000USD-17,400,000USD-7,900,000USD-8,400,000USD-432,000,000USD
    Issuance Of Capital Stock2,600,000USD2,500,000USD3,300,000USD3,300,000USD0USD0USD——
    Change In Cash611,900,000USD-257,500,000USD-268,900,000USD556,300,000USD-143,800,000USD358,900,000USD101,800,000USD19,400,000USD
    Begin Period Cash Flow736,100,000USD993,600,000USD1,262,500,000USD706,200,000USD850,000,000USD491,100,000USD389,300,000USD369,900,000USD
    End Period Cash Flow1,348,000,000USD736,100,000USD993,600,000USD1,262,500,000USD706,200,000USD850,000,000USD491,100,000USD389,300,000USD
    Other Cashflows From Investing Activities-48,900,000USD2,476,700,000USD280,600,000USD1,520,800,000USD-394,400,000USD22,100,000USD28,000,000USD-892,400,000USD
    Other Cashflows From Financing Activities-234,900,000USD205,600,000USD-229,800,000USD362,900,000USD1,588,300,000USD-205,000,000USD-66,100,000USD-27,200,000USD
    Unclassified Operating Cash Flow-476,500,000USD-767,600,000USD-387,100,000USD—675,700,000USD-213,200,000USD-192,600,000USD—
    Unclassified Investing Cash Flow—-2,150,700,000USD-1,474,800,000USD-1,077,800,000USD786,400,000USD659,100,000USD378,000,000USD1,144,500,000USD
    Change To Liabilities———170,200,000USD-70,400,000USD-82,700,000USD-96,300,000USD220,300,000USD
    Unclassified Financing Cash Flow———-361,800,000USD-2,084,800,000USD16,400,000USD—399,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentDeveloped Markets2,193,700,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentEmerging Markets542,300,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentGreater China713,800,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentJapan Australia And New Zealand296,100,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentDeveloped Markets2,020,800,000USD0001792044-26-000029
    Q1 2026Quarterly · 2026-03-31SegmentEmerging Markets535,400,000USD0001792044-26-000029
    Q1 2026Quarterly · 2026-03-31SegmentJapan Australia And New Zealand273,400,000USD0001792044-26-000029
    Q1 2026Quarterly · 2026-03-31SegmentOther680,100,000USD0001792044-26-000029
    Q4 2025Quarterly · 2025-12-31SegmentDeveloped Markets2,247,400,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentEmerging Markets564,700,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentJapan Australia And New Zealand305,700,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentOther572,900,000USDLegacy provider
    FY 2025Yearly · 2025-12-31SegmentDeveloped Markets8,514,000,000USD0001792044-26-000013
    FY 2025Yearly · 2025-12-31SegmentEmerging Markets2,210,100,000USD0001792044-26-000013
    FY 2025Yearly · 2025-12-31SegmentJapan Australia And New Zealand1,193,800,000USD0001792044-26-000013
    FY 2025Yearly · 2025-12-31SegmentOther2,332,500,000USD0001792044-26-000013
    Q3 2025Quarterly · 2025-09-30SegmentDeveloped Markets2,255,600,000USD0001792044-25-000046
    Q3 2025Quarterly · 2025-09-30SegmentEmerging Markets570,400,000USD0001792044-25-000046
    Q3 2025Quarterly · 2025-09-30SegmentJapan Australia And New Zealand306,300,000USD0001792044-25-000046
    Q3 2025Quarterly · 2025-09-30SegmentOther615,200,000USD0001792044-25-000046
    Q2 2025Quarterly · 2025-06-30SegmentDeveloped Markets2,119,300,000USD0001792044-25-000033
    Q2 2025Quarterly · 2025-06-30SegmentEmerging Markets555,100,000USD0001792044-25-000033
    Q2 2025Quarterly · 2025-06-30SegmentJapan Australia And New Zealand305,700,000USD0001792044-25-000033
    Q2 2025Quarterly · 2025-06-30SegmentOther588,900,000USD0001792044-25-000033
    Q1 2025Quarterly · 2025-03-31SegmentDeveloped Markets1,891,700,000USD0001792044-26-000029
    Q1 2025Quarterly · 2025-03-31SegmentEmerging Markets519,900,000USD0001792044-26-000029
    Q1 2025Quarterly · 2025-03-31SegmentJapan Australia And New Zealand276,100,000USD0001792044-26-000029
    Q1 2025Quarterly · 2025-03-31SegmentOther555,500,000USD0001792044-26-000029
    Q4 2024Quarterly · 2024-12-31SegmentDeveloped Markets2,146,100,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentEmerging Markets513,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentJapan Australia And New Zealand334,500,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentOther521,800,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentDeveloped Markets8,929,400,000USD0001792044-26-000013
    FY 2024Yearly · 2024-12-31SegmentEmerging Markets2,250,700,000USD0001792044-26-000013
    FY 2024Yearly · 2024-12-31SegmentJapan Australia And New Zealand1,346,200,000USD0001792044-26-000013
    FY 2024Yearly · 2024-12-31SegmentOther2,166,500,000USD0001792044-26-000013
    Q3 2024Quarterly · 2024-09-30SegmentDeveloped Markets2,298,700,000USD0001792044-25-000046
    Q3 2024Quarterly · 2024-09-30SegmentEmerging Markets533,200,000USD0001792044-25-000046
    Q3 2024Quarterly · 2024-09-30SegmentJapan Australia And New Zealand344,300,000USD0001792044-25-000046
    Q3 2024Quarterly · 2024-09-30SegmentOther561,800,000USD0001792044-25-000046
    FY 2023Yearly · 2023-12-31SegmentDeveloped Markets9,251,900,000USD0001792044-26-000013
    FY 2023Yearly · 2023-12-31SegmentEmerging Markets2,551,600,000USD0001792044-26-000013
    FY 2023Yearly · 2023-12-31SegmentJapan Australia And New Zealand1,424,500,000USD0001792044-26-000013
    FY 2023Yearly · 2023-12-31SegmentOther2,160,400,000USD0001792044-26-000013
    FY 2022Yearly · 2022-12-31SegmentDeveloped Markets9,768,900,000USD0001792044-25-000008
    FY 2022Yearly · 2022-12-31SegmentEmerging Markets2,615,600,000USD0001792044-25-000008
    FY 2022Yearly · 2022-12-31SegmentJapan Australia And New Zealand1,632,400,000USD0001792044-25-000008
    FY 2022Yearly · 2022-12-31SegmentOther2,201,200,000USD0001792044-25-000008
    FY 2021Yearly · 2021-12-31SegmentDeveloped Markets10,428,700,000USD0001792044-24-000008
    FY 2021Yearly · 2021-12-31SegmentEmerging Markets3,144,700,000USD0001792044-24-000008
    FY 2021Yearly · 2021-12-31SegmentJapan Australia And New Zealand2,027,400,000USD0001792044-24-000008
    FY 2021Yearly · 2021-12-31SegmentOther2,212,800,000USD0001792044-24-000008
    FY 2020Yearly · 2020-12-31SegmentDeveloped Markets8,510,900,000USD0001792044-23-000008
    FY 2020Yearly · 2020-12-31SegmentEmerging Markets1,853,800,000USD0001792044-23-000008
    FY 2020Yearly · 2020-12-31SegmentJapan Australia And New Zealand1,195,300,000USD0001792044-23-000008
    FY 2020Yearly · 2020-12-31SegmentOther259,900,000USD0001792044-23-000008
    Q4 2020Quarterly · 2020-12-31ProductBrands1,859,000,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductComplex GXAnd Biosimilars338,800,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductGenerics1,389,900,000USDLegacy provider
    Q4 2020Quarterly · 2020-12-31ProductOther126,100,000USDLegacy provider
    FY 2020Yearly · 2020-12-31ProductBrands5,234,900,000USD0001792044-23-000008
    FY 2020Yearly · 2020-12-31ProductComplex GXAnd Biosimilars1,295,500,000USD0001792044-23-000008
    FY 2020Yearly · 2020-12-31ProductGenerics5,289,500,000USD0001792044-23-000008
    FY 2020Yearly · 2020-12-31ProductOther126,100,000USD0001792044-23-000008
    Q3 2020Quarterly · 2020-09-30ProductBrands1,241,400,000USD0001792044-21-000035
    Q3 2020Quarterly · 2020-09-30ProductComplex GXAnd Biosimilars352,300,000USD0001792044-21-000035
    Q3 2020Quarterly · 2020-09-30ProductGenerics1,354,400,000USD0001792044-21-000035
    Q2 2020Quarterly · 2020-06-30ProductBrands1,073,000,000USD0001792044-21-000026
    Q2 2020Quarterly · 2020-06-30ProductComplex GXAnd Biosimilars351,100,000USD0001792044-21-000026
    Q2 2020Quarterly · 2020-06-30ProductGenerics1,271,800,000USD0001792044-21-000026
    Q1 2020Quarterly · 2020-03-31ProductBrands1,061,500,000USD0001792044-21-000018
    Q1 2020Quarterly · 2020-03-31ProductComplex GXAnd Biosimilars253,300,000USD0001792044-21-000018
    Q1 2020Quarterly · 2020-03-31ProductGenerics1,273,400,000USD0001792044-21-000018
    FY 2019Yearly · 2019-12-31SegmentDeveloped Markets8,240,000,000USD0001792044-22-000010
    FY 2019Yearly · 2019-12-31SegmentEmerging Markets1,723,200,000USD0001792044-22-000010
    FY 2019Yearly · 2019-12-31SegmentJapan Australia And New Zealand1,192,500,000USD0001792044-22-000010
    FY 2019Yearly · 2019-12-31SegmentOther214,600,000USD0001792044-22-000010
    FY 2019Yearly · 2019-12-31ProductBrands5,362,100,000USD0001792044-22-000010
    FY 2019Yearly · 2019-12-31ProductComplex GXAnd Biosimilars1,211,300,000USD0001792044-22-000010
    FY 2019Yearly · 2019-12-31ProductGenerics4,796,900,000USD0001792044-22-000010
    FY 2019Yearly · 2019-12-31ProductOther130,200,000USD0001792044-22-000010
    FY 2018Yearly · 2018-12-31SegmentDeveloped Markets8,289,100,000USD0001792044-21-000009
    FY 2018Yearly · 2018-12-31SegmentEmerging Markets1,678,700,000USD0001792044-21-000009
    FY 2018Yearly · 2018-12-31SegmentJapan Australia And New Zealand1,132,800,000USD0001792044-21-000009
    FY 2018Yearly · 2018-12-31SegmentOther168,100,000USD0001792044-21-000009
    FY 2018Yearly · 2018-12-31ProductBrands5,523,700,000USD0001792044-21-000009
    FY 2018Yearly · 2018-12-31ProductComplex GXAnd Biosimilars522,600,000USD0001792044-21-000009
    FY 2018Yearly · 2018-12-31ProductGenerics5,222,400,000USD0001792044-21-000009

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.